Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors

By WebmasterJanuary 12, 2023November 1st, 2024No Comments

Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors

Previous PostiVIEW announces Completion of First Patient Treatment in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis
Next PostScipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time